Describe the structure of a family.
Identify the strengths in the family.
Explain where in the life cycle this family is located and how that may influence family dynamics.
Describe the specific roles of two family members, and explain if the various roles work well together for the benefit of this family.
Explain how understanding the family’s challenges will help a social worker working with this family.
Analyze this family using systems theory or the ecological perspective.
The structure of a family refers to the roles and relationships between family members. Families can come in many different forms, including nuclear families, single-parent households, blended families, extended families, and adoptive families (McGoldrick et al., 2018). Regardless of their composition, all families share certain characteristics such as a commitment to one another and mutual support during difficult times (Manning & Lamb 2010).
A typical nuclear family consists of two married parents who are related biologically or through adoption to their children (Furstenberg et al., 1999). This type of family is marked by its similarity in beliefs and values that tend to be passed on within generations. In addition to providing stability for both adults and children, the traditional two parent household is also associated with economic advantages due to shared resources (Seltzer 2001).
This particular family is positioned at an intermediate phase in the life cycle where adult responsibilities such as managing finances and raising children start increasing while certain freedoms enjoyed during adolescence gradually decrease. As such it may become more challenging for this family to keep up with day-to-day demands while still allowing time for leisure activities which serve as a source of renewal from stressors encountered throughout life’s journey (Belsky & Rovine 1990) The couple must now learn how best balance work-home obligations efficiently without compromising either aspect too heavily.
Despite these potential challenges at this stage in the family life cycle there are also numerous strengths present. With both partners having had ample time to mature before becoming parents they usually have greater emotional intelligence when it comes responding sensitively towards each other’s needs as well making effective parenting decisions(Cowan & Cowan 2000) Additionally since the relationship has been established over many years couples often possess better conflict resolution skills compared those just entering into unions.
In conclusion, this particular nuclear family provides examples of common dynamics experienced by most households irrespective of whether they comprise married couples or single mothers/fathers. These individuals embody various strengths stemming from their place at an intermediary point within the life cycle . Herein lies both opportunities for growth along with potential pitfalls depending on how adeptly members respond positively towards emerging obstacles.
The basic aim of the personalized medicine is applying right therapy to the right population of people by defining disease at the moecular level. So, identifying differences among the individuals support the new treatment methods and pharmaceutical companies to develop new cancer drugs. Patients who have similar clinical outcome and histological tumor type can give different response to the same drug(17). Prediction of who will be a nonresponders reduces the harmfull effect of drug on nonresponders like a potential toxic effect of drug and cost effect. Also when drug companies develop new drug, they focus on the patient population that benefit from drug to increase positive responds(17).
U.S. Food and Drug Administration bringed development about targeted therapy. For example, to treat chronic myeloid leukemia and gastrointestinal stromal tumor(18) ,imatinib mesylate is used and to treat breast cancer(19), trastuzumab (Herceptin) is used. Molecular characteristics of these cancer types that are abnormal protein tyrosine kinase activity in chronic myeloid leukemia and gastrointestinal stromal tumor and HER-2 receptor in breastcancer is used as a predictive biomarker. By using these markers only individuals which have these molecular alteration is selected and it means they are favorable for the treatment. Using this way some cancer types’ survival rate is shifted from 0 to 70%(17).
This application is used in non-small cell lung cancer treatment with using of mutations screeing. In this cancer type mutation occurs in kinase domain of EGFR. Gefitinib (Iressa) and erlotinib are tyrosine kinase inhibitors drug are used to treat and patients give a higher response to the treatment(20). Also if patient that is never smoked Asian females have adenocarcinomas, these drugs efficient on them(21). On the other hand, if the mutatuions occur at downstream effector KRAS, patient is resistant to to erlotinib(22). Also mutations that is at KRAS have a resistance to cetuximab (Erbitux) and panitumumab (Vectibix) drugs in colon cancer patients. If the KRAS is wild type, these these drugs is effective on the patients(23). These responses that are specific and different are based on molecular profile. Some molecular test are done before the using of cetuximab or panitu